世界中医药
文章摘要
引用本文:申广文,刘颖,李强,郑华飞.丹鸡活血汤辅助治疗慢性乙型肝炎肝纤维化对患者肝功能及血清炎性反应介质的影响[J].世界中医药,2018,(09):.  
丹鸡活血汤辅助治疗慢性乙型肝炎肝纤维化对患者肝功能及血清炎性反应介质的影响
Effects of Adjuvant Therapy with Danji Huoxue Decoction on Liver Function and Serum Inflammatory Factors in Patients with Chronic Hepatitis B Liver Fibrosis
投稿时间:2018-06-25  
DOI:10.3969/j.issn.1673-7202.2018.09.011
中文关键词:  慢性乙型肝炎  肝纤维化;丹鸡活血汤;肝功能;炎性反应介质
English Keywords:Chronic hepatitis B liver fibrosis  Danji Huoxue Decoction  Liver function  Inflammatory factor
基金项目:邯郸市科学技术局科技项目(0923108144)
作者单位
申广文,刘颖,李强,郑华飞 河北省邯郸市传染病医院邯郸056002 
摘要点击次数: 686
全文下载次数: 672
中文摘要:
      目的:探讨丹鸡活血汤辅助治疗慢性乙型肝炎肝纤维化对患者肝功能及血清炎性反应介质的影响。方法:选取2015年3月至2017年3月邯郸市传染病医院收治的慢性乙型肝炎肝纤维化患者160例,随机分为观察组与对照组,每组80例。对照组采用常规护肝治疗,观察组在对照组的基础上给予丹鸡活血汤治疗,3个月为1个疗程,2组均连续治疗2个疗程。比较2组治疗前后中医证候积分、肝功能指标、肝纤维化指标及血清炎性反应介质变化。结果:与治疗前比较,治疗后2组肝部不适或疼痛、舌质暗红、面色晦暗、食欲衰退与乏力等主要中医证候积分均显著下降(P<0.05),且观察组显著低于对照组(P<0.05);与治疗前比较,治疗后2组血清丙氨酸转氨酶(ALT)、总胆红素(TBIL)、天门冬氨酸转氨酶(AST)均显著下降(P<0.05),且观察组显著低于对照组(P<0.05);白蛋白(ALB)显著升高(P<0.05),且观察组显著高于对照组(P<0.05);与治疗前比较,治疗后2组血清透明质酸(HA)、层粘连蛋白(LN)、Ⅲ型前胶原肽(PC-Ⅲ)、Ⅳ型胶原(Ⅳ-C)、基质金属蛋白酶-1(MMP-1)、白细胞介素-6(IL-6)及肿瘤坏死因子-α(TNF-α)及观察组丙二醛(MDA)水平均显著下降(P<0.05),且观察组均显著低于对照组(P<0.05)。结论:丹鸡活血汤辅助治疗慢性乙型肝炎肝纤维化可有效改善患者临床症状,改善其肝功能的同时抑制肝纤维化进展,其作用机制可能与其降低炎性反应介质水平有关。
English Summary:
      To explore the effects of adjuvant therapy with Danji Huoxue Decoction on liver function and serum inflammatory factors in patients with chronic hepatitis B liver fibrosis.Methods:A total of 160 patients with chronic hepatitis B liver fibrosis treated in Handan Hospital of Infectious Disease from March 2015 to March 2017 were selected and randomly divided into observation group and control group,with 80 cases in each group.Control group was treated with routine liver protection while observation group was treated with Danji Huoxue Decoction on the basis of the same treatment.Both groups were continuously treated for 2 courses (3 months as a course).The changes of Traditional Chinese Medicine (TCM) syndromes scores,liver function index,liver fibrosis index and serum inflammatory factor level in both groups were compared before and after treatment.Results:Compared with before treatment,the scores of major TCM syndromes such as liver discomfort or pain,dark red tongue,dark complexion,loss of appetite and fatigue of both groups were significantly decreased after treatment (P<0.01),and observation group decreased more significantly than control group (P<0.05 or P<0.01).Compared with before treatment,the serum ALT,TBILN,AST levels decreased significantly in both groups after treatment (P<0.01),and the levels of observation group decreased more significantly than control group (P<0.05 or P<0.01).ALB levels increased significantly (P<0.01),and observation group increased more significantly than control group (P<0.05 or P<0.01).Compared with before treatment,the serum HA,LN,PC-Ⅲ,Ⅳ-C,MMP-1,IL-6,TNF-α of both groups and the MDA level of observation group were significantly decreased (P<0.05 or P<0.01),and the levels of MDA in the observation group significantly decreased after treatment.The observation group decreased more significantly than control group (P<0.05 or P<0.01).Conclusion:The adjuvant therapy with Danji Huoxue Decoction in the treatment of chronic hepatitis B liver fibrosis can effectively improve the clinical symptoms,improve the liver function and inhibit the progress of liver fibrosis.Its mechanism may be related to the reduction of inflammatory factors level.
查看全文  查看/发表评论  下载PDF阅读器